Carregant...
Agonist‐induced desensitisation of β(3)‐adrenoceptors: Where, when, and how?
β(3)‐Adrenoceptor agonists have proven useful in the treatment of overactive bladder syndrome, but it is not known whether their efficacy during chronic administration may be limited by receptor‐induced desensitisation. Whereas the β(2)‐adrenoceptor has phosphorylation sites that are important for d...
Guardat en:
| Publicat a: | Br J Pharmacol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6592865/ https://ncbi.nlm.nih.gov/pubmed/30809805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14633 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|